Arrhythmia

Arrhythmia – Irregularity of heart beats

Causes

Cardiac: MI, coronary artery disease, LV aneurysm, mitral valve disease, cardiomyopathy, percarditis, myocarditis, aberrant conduction pathways

Non-cardiac: Caffeine, smoking, alcohol, pneumonia, drugs (beta2-agonists, digoxin, L-dopa, tricyclics, adriamycin, doxorubicin), metabolic imbalance (K, Ca, Mg, hypoxia, hypercapnia. metabolic acidosis, thyroid disease, phaeochromocytoma).

Presentation

Palpitation, chest pain, presyncope/syncope, hypotension, or pulmonary oedema

Some arrhythrnias may be asymptomatic and incidental

eg AF.

Tests

FBC, U&E, glucose, Ca, Mg, TSH

ECG: Look for signs of IHD, AF, short PR interval (WPW syndrome), long QT interval (metabolic imbalance, drugs, congenital), U waves (hypokalaemia). 24h ECG monitoring;

Echo: To look for structural heart disease, eg mitral steriosis

Provocation tests: Exercise ECG, cardiac catheterization, and electrophysiological studies


Treatment

Bradycardia

Treat the cause

HR <40bpm style="font-family: Wingdings;">à give IV atropine 0.6—1.2mg (up to maximum of 3mg).

If no response à temporary pacing wire

If necessary àisoprenaline infusion or use external cardiac pacing.

Sick sinus syndrome

Pace if symptomatic.

Narrow Complex tachycardia (>100bpm + QRS <120ms)

Sinus tachycardia: normal P wave followed by normal QRS.

SVT: p wave absent or inverted after QRS.

AF: absent P wave, irregular QRS complexes.

Atrial flutter: atrial rate usually 300bpm giving flutter waves or ‘sawtooth’ baseline, ventricular rate often l50bpm (2:1 block).

Atrial tachycardia: abnormally shaped P waves may outnumber QRS.

Multifocal atrial tachycardia: 3 or more p wave morphologies, irregular QRS complexes.

junctional tachycardia: rate 150-250bpm, P wave either buried in QRS complex or occurring after QRS complex.


Sinus tachycardia

Treat the cause

SVT

Adenosine

If fails à use verapamil 5-10mg iv over 2min, or over 3mm if elderly. If fails à give further dose of 5mg IV after 5-10min. Alternatives: atenolol 2.5mg iv at 1 mg/min repeated at 5mm intervals to a maximum of 10mg or sotalol 20—60mg iv.

If fails à DC cardioversion.

AF/flutter

Common causes:

Heart failure; hypertension; cardiac ischaemia; MI (seen in

22%); mitral valve disease; pneumonia: hyperthyroidism: alcohol

Rare causes:

Cardiomyopathy, constrictive pericarditis, sick sinus syndrome, bronchial carcinoma, atrial myxoma, endocarditis, haemochromatosis, sarcoidosis

ECG in AF/flutter

Atrial flutter

P wave rate 300/min

Sawtoothed pattern

2:1, 3:1 or 4:1 block

Block increased by carotid sinus pressure

Atrial fibrillation

QRS complex characteristically over 160/min without treatment, but can be slower

No P waves identifiable, but there is a varying, completely irregular baseline


Treatment of AF

Acute AF (eg <72h)

Treat any associated acute illness (eg MI, pneumonia)

To control ventricular rate à digoxin PO (0.5mg/12h, 2 doses, then 0.125-0.25mg daily) or iv (0.75-1mg in 0.9% NaCl over 2h).

If ventricular rate still too fast and LV function is adequate à low dose beta-blocker (eg metoprolol 50mg/12h PO; use 10mg/8h if LV function is poor) and gradually increase dose.

If AF does not resolve à drug or electrical cardioversion.

Drug cardioversion: amiodarone IVI (5mg/kg over 1h then ~900mg over 24h via a central line max 1.2g in 24h) or PO (200mg/8h for lwk, 200mg/12h for lwk, 100—200mg/24h maintenance). Alternative: flecainide 2mg/kg iv over >25mm (max 150mg) with ECG monitoring. 300mg stat PC may also work.

DC cardioversion is indicated: (1) electively, following a first attack of AF with an identifiable cause; (2) as an emergency, if the patient is compromised.

If AF is of recent onset with a structurally normal heart on echo, anticoagulation is not required but aspirin may be given. Otherwise, anticoagulate with warfarin for 3wks before and 4wks after DC cardioversion.

Chronic AF

Control rate with digoxin PO: loading dose (0.5mg/12h, two doses) followed by maintenance (0.125—0.25mg/24h). In the elderly, load with 0.75mg in total and use 0.0625-.0.125mg/24h.

If rate still too fast, check compliance and serum level (take blood >6h after last dose), cautiously increase dose or consider low-dose beta-blocker (eg metoprolol), Alternative: amiodarone PO.

If >65yr à warfarin Aim for an INR of 2.5—3.5.

IF <65yr style="font-size: 10pt;">(eg hypertension, diabetes, LV dysfunction, increased LA size, rheumatic valve disease, MI), or those in whom warfarin is contraindicated à aspirin (300mg PO)


Paroxysmal AF

Sotalol 80mg/24h PO (after at least 48h, gradually increase dose to 80mg/12h. then l60mg/12h; monitor QT interval).

Alternative: amiodarone PO. Anticoagulate with warfarin.

Treatment summary for AF

Treat any reversible cause.

Control ventricular rate.

Consider cardioversion to sinus rhythm, if onset within last 12 months (do echo first is heart structurally normal?).

Prevent emboli: warfarin (or aspirin)

Treatment of Atrial flutter

Consider cavotricuspid isthmus ablation

Atrial tachycardia

If digoxin toxicity à stop digoxin; digoxinspecific antibody fragments. Maintain K at 4-5mmol/L

Mulifocal atrial tachycardia

Most commonly occurs in COPD.

Correct hypoxia and hypercapnia.

Consider verapamil if rate remains >110bpm.

Junctional tachycardia

There are 3 types of junctional tachycardia:

AV nodal re-entry tachycardia (AVNRT)

AV re-entry tachycardia (AVRT)

His bundle tachycardia

Treatment

vagal manoeuvres

Adenosine

If it recurs, treat with a beta-blocker or amiodarone.

Radiofrequency ablation

Broad complex tachycardia (>100bpm + QRS >120ms)

Differential Dx:

VT; include Torsade de pointes

SVT with aberrant conduction, eg AF, atrial flutter

ECG findings in favour of VT:

Positive QRS concordance in chest leads

Marked LAD

AV dissociation (occurs in 25%) or 2: 1 or 3: 1 AV block

Fusion beats or capture beats

RSR complex in V1 (with positive QRS in V1)

QS complex in V6 (with negative QRS in V1).


Management

Connect to a cardiac monitor; have a defibrillator to hand.

Give high-flow oxygen by face mask

Obtain IV access and take blood for U&E, cardiac enzymes, Ca, Mg.

Obtain 12-lead ECG

ABG (if evidence of pulmonary oedema, reduced conscious level, sepsis).

VT: Haemodynamicaliy stable

Correct hypokalaemia and hypomagnaesemia

Amiodarone 150mg IV over 10min, then 300mg over 1hr or lignocaine 50mg over 2mm repeated every 5min to 200mg max

If this fails, or cardiac arrest occurs, use DC shock

After correction of VT, establish the cause from history/investigations.

Maintenance antiarrhythmic therapy may be required. If VT occurs <24h>24h after MI, give IV lidocaine infusion and start oral antiarrhythmic: eg amiodarone.

Prevention of recurrent VT: Surgical isolation of the arrhythmogenic area or implantation of tiny automatic defibrillators may help.

VF

Use asynchronized DC shock

Ventricular extrasystoles (ectopics)

In post MI, there is a risk of VF if 'R on T' pattern is seen.

If frequent (>10/min), treat with lignocamne 100mg IV


Torsade de pointes

Mg sulfate, 8mmol over 15mm (≈4mL of 50% solution) ± overdrive pacing.

Indications for temporary cardiac pacing

Symptomatic bradycardia, unresponsive to atropine.

Acute conduction disturbances following MI:

After acute anterior MI, prophylactic pacing is required in:

Complete AV block

Mobitz type I AV block (Wenckebach)

Mobitz type II AV block

Non-adjacent bifascicular or trifascicular block

After inferior MI

Suppression of drug-resistant tachyarrhythmias, eg SVT, VT.

Special situations: During general anaesthesia; during cardiac surgery; during electrophysiological studies; drug overdose (eg digoxin, 3-blockers, vera- pamil).

Indications for a permanent pacemaker

Complete AV block (Stokes – Adams attacks, asymptomatic, congenital)

Mobitz type II AV block

Persistent AV block after anterior MI

Symptornatic bradycardias (eg sick sinus syndrome)

Drug-resistant tachyarrhythmias.

Antiarrhythmic Drugs

Group IA

Quinidine sulfate

Quinidine gluconate

Procainamide

Disopyramide

Group lB

Lidocaine

Mexiletine

Group IC

Flecainide

Propafenone

Group II

Metroprolol

Group III

Amiodarone

Ibutilide

Dofetilide

Bretylium

Sotalol

Group IV

Verapamil

Diltiazem

Other

Digoxin

Adenosine

Comments

Popular Posts